Long-Term Management and Adverse Effect Management with Lorlatinib – Weight Gain
This Medudy course is a video tutorial for physicians on the topic of “Long-Term Management and Side Effect Management with Lorlatinib—Weight Gain.” In this video, Dr. Carolin Groß-Ophoff, senior physician in hematology and oncology at the City of Cologne Hospitals, discusses the ALK tyrosine kinase inhibitor lorlatinib, which is approved for the treatment of advanced, ALK-positive non-small cell lung cancer. Due to its […]
Long-Term Management and Adverse Effect Management with Lorlatinib – CNS Effects
This Medudy course is a video tutorial for physicians on the topic of “Long-Term Management and Side Effect Management with Lorlatinib—CNS Effects.” In this video, Dr. Carolin Groß-Ophoff, senior physician in hematology and oncology at the City of Cologne Hospitals, discusses the ALK tyrosine kinase inhibitor lorlatinib, which is approved for the treatment of advanced, ALK-positive non-small cell lung cancer. Due to its […]